Search research articles
Contact Us
Filters
Showing results (11-20 of 296) with videos related to
Page
of 30
Sort By:
Breast Cancer Research and Treatment
|
February 18, 2010
Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapy
Aditya Bardia, Vered Stearns
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2013
Neoadjuvant therapy as a platform for drug development and approval in breast cancer
Aditya Bardia, José Baselga
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2018
Cycling Toward Progress: Ribociclib, a CDK 4/6 Inhibitor for Breast Cancer
Laura Spring, Aditya Bardia
Targeted Oncology
|
May 3, 2023
HER2-Low Breast Cancer-Diagnostic Challenges and Opportunities for Insights from Ongoing Studies: A Podcast
Aditya Bardia, Giuseppe Viale
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2024
Cracking the Genomic Code of CDK4/6 Inhibitor Resistance
Seth A Wander, Aditya Bardia
The New England Journal of Medicine
|
September 29, 2006
Images in clinical medicine. Intratracheal melanoma metastases
Aditya Bardia, Ravi D Rao
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2014
Solidifying liquid biopsies: can circulating tumor cell monitoring guide treatment selection in breast cancer?
Aditya Bardia, Daniel A Haber
The Oncologist
|
April 12, 2012
Trastuzumab for small HER-2+ breast cancer: small tumor, big decision
Roisin M Connolly, Aditya Bardia
Oncology (Williston Park, N.Y.)
|
May 13, 2021
Novel Therapies for Metastatic Triple-Negative Breast Cancer: Spotlight on Immunotherapy and Antibody-Drug Conjugates
Aiko Nagayama, Neelima Vidula, Aditya Bardia
The New England Journal of Medicine
|
February 19, 2025
Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer. Reply
Aditya Bardia, Maria Schwaederle, Giuseppe Curigliano
Page
of 30
Search research articles
Search
Showing results (11-20 of 296) with videos related to
Sort By:
Page
of 30
Breast Cancer Research and Treatment
|
February 18, 2010
Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapy
Aditya Bardia, Vered Stearns
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2013
Neoadjuvant therapy as a platform for drug development and approval in breast cancer
Aditya Bardia, José Baselga
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2018
Cycling Toward Progress: Ribociclib, a CDK 4/6 Inhibitor for Breast Cancer
Laura Spring, Aditya Bardia
Targeted Oncology
|
May 3, 2023
HER2-Low Breast Cancer-Diagnostic Challenges and Opportunities for Insights from Ongoing Studies: A Podcast
Aditya Bardia, Giuseppe Viale
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2024
Cracking the Genomic Code of CDK4/6 Inhibitor Resistance
Seth A Wander, Aditya Bardia
The New England Journal of Medicine
|
September 29, 2006
Images in clinical medicine. Intratracheal melanoma metastases
Aditya Bardia, Ravi D Rao
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2014
Solidifying liquid biopsies: can circulating tumor cell monitoring guide treatment selection in breast cancer?
Aditya Bardia, Daniel A Haber
The Oncologist
|
April 12, 2012
Trastuzumab for small HER-2+ breast cancer: small tumor, big decision
Roisin M Connolly, Aditya Bardia
Oncology (Williston Park, N.Y.)
|
May 13, 2021
Novel Therapies for Metastatic Triple-Negative Breast Cancer: Spotlight on Immunotherapy and Antibody-Drug Conjugates
Aiko Nagayama, Neelima Vidula, Aditya Bardia
The New England Journal of Medicine
|
February 19, 2025
Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer. Reply
Aditya Bardia, Maria Schwaederle, Giuseppe Curigliano
Page
of 30